2 September 2026, Valencia, Spain — iPremom, a molecular diagnostics company dedicated to the earliest prediction of pregnancy complications, has raised €15m in seed funding led by Amadeus Capital Partners, with participation from Asabys Partners and APEX Ventures.
2 September 2026, Valencia, Spain — iPremom, a molecular diagnostics company dedicated to the earliest prediction of pregnancy complications, has raised €15m in seed funding led by Amadeus Capital Partners, with participation from Asabys Partners and APEX Ventures.